The vaccine can be administered to those 12 years and above. This will be India’s sixth Covid vaccine to have received emergency nod.
Zydus Cadila had applied for the authorization of ZyCoV-D on July 1. It had conducted late-stage trial of over 28,000 volunteers and showed an efficacy of 66.6%.
An expert panel had recommended granting emergency use authorisation to Zydus Cadila’s three-dose COVID-19 vaccine ZyCoV-D.
The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) deliberated on the application given by Zydus
on Thursday and recommended granting emergency use authorisation to its three-dose coronavirus vaccine.
The recommendations were sent to the Drugs Controller General of India (DCGI) for final approval.
(With inputs from PTI)